R&D

R&D is
the heart of our mission to develop global medicines for incurable diseases.

Pipeline for New Medicine

Immunological disease projects

Immunological
Project code Indications Discovery Preclinical Phase1 Phase2 Phase3 Partners
HL036 Dry Eye Disease
complete
complete
complete
complete
대웅제약 하버바이오메드
HL61 Autoimmune diseases
complete
complete
complete
로이반트 하버바이오메드
HL189 / HL190 Uveitis, wAMD
complete
complete

Cancer projects

Cancer projects
Project code Indications Discovery Preclinical Phase1 Phase2 Phase3 Partners
IM156 Oncology Tumor
metabolism
complete
complete
complete
이뮤노멧
HL186 Immuno-oncology
complete
대웅제약
HL187 Immuno-oncology
complete
대웅제약